Back to STATE STREET CORP STATE STREET CORP

BBIOBBIO
11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in BRIDGEBIO PHARMA INC

STATE STREET CORP holds 4.4M shares of BBIO (BRIDGEBIO PHARMA INC), worth $330.4M as of 2026-Q2. The position was decreased (-10.1% shares). BBIO represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$330.4M

Current Shares

4.4M

Total Value Change

+$125M

Total Shares Change

-650,967

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
4.4M
-10.1%
$330.4M0.0%$74.48
0
2026-Q1
Decreased
4.9M
-0.6%
$366.4M0.0%$74.26
0
2025-Q4
Decreased
5M
-11.5%
$379.6M0.0%$76.49
0
2025-Q3
Decreased
5.6M
-4.9%
$291.2M0.0%$51.94
0
2025-Q2
Increased
5.9M
+2.6%
$254.6M0.0%$43.18
32
2025-Q1
Decreased
5.7M
-7.0%
$198.8M0.0%$34.57
0
2024-Q4
Increased
6.2M
+3.7%
$169.7M0.0%$27.44
32
2024-Q3
Increased
6M
+1.9%
$151.8M0.0%$25.46
31
2024-Q2
Increased
5.9M
+8.6%
$148.3M0.0%$25.33
33
2024-Q1
Increased
5.4M
+6.0%
$166.7M0.0%$30.92
32
2023-Q4
New
5.1M
-
$205.4M0.0%$40.37
42

Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used